Immunization, HIB
This immunization is designed to prevent diseases caused by Haemophilus influenzae type B (HIB), a bacteria responsible for a range of serious “invasive” diseases including meningitis with potential brain damage and epiglottitis with airway obstruction.
More than 90% of all HIB infections occur in children 5 years of age or less; the peak attack rate is at 6-12 months of age.
The HIB vaccine is usually given at 2, 4 and 6 months of age and a final booster is given at 12-15 months of age. HIB vaccine rarely causes severe reactions. The HIB vaccine has almost eradicated the disease. Before the vaccine, some 20,000 cases of HIB invasive disease in preschool children were reported every year in the U.S. compared to less than 300 cases after the advent of the vaccine.
The HIB vaccine is a “conjugate” vaccine. It joins (“conjugates”) sugars from the HIB bacteria with a protein from another bacteria. The protein stimulates the baby’s immature immune cells so they produce antibodies to the HIB sugars, protecting the child from HIB infection.
The prestigious Albert Lasker Award for Clinical Medical Research was given in 1996 to David H. Smith, Porter W. Anderson Jr., John B. Robbins and Rachel Schneerson for their work in developing a vaccine against Haemophilus influenzae type B.
Read Also:
- Immunization, infectious hepatitis
See Immunization, hepatitis A.
- Immunization, meningococcal
1906-1910) showed that college students who live on campus have triple the risk of acquiring meningococcal infection compared with their peers who live off-campus. Among the factors cited for a higher risk of the disease on campus were the relative crowding associated with dormitory residence, alcohol-related behaviors, and exposure to tobacco smoke. The same factors […]
- Immunization, MMR
The standard vaccine given to prevent measles, mumps and rubella (German measles). See childhood vaccination schedule.
- Immunization, pneumococcal
1) the indications for which PPSV23 vaccination is recommended now include smoking and asthma, and 2) routine use of PPSV23 is no longer recommended for Alaska Natives or American Indians aged
- Immunization, polio
oral polio vaccine (OPV) and inactivated polio vaccine (IPV). OPV was formerly recommended for children in the U.S. but was shown to actually cause polio in extremely rare cases and is no longer recommended. IPV is given as a shot in the arm or leg.